NASDAQ:ILMN
Illumina Stock News
$124.68
+1.63 (+1.32%)
At Close: May 01, 2024
Here are the 20 worst-performing stocks among the S&P 500 in 2023
11:18am, Friday, 29'th Dec 2023
The U.S. stock market staged a remarkable rally in 2023, but 173 stocks in the S&P 500 were still down for the year.
Here's Why You Should Retain Illumina (ILMN) Stock for Now
02:17pm, Thursday, 28'th Dec 2023
Investors are optimistic about Illumina's (ILMN) strength in the genomics market and strong solvency position.
Illumina To Webcast Upcoming Investor Conference
04:05pm, Tuesday, 19'th Dec 2023
SAN DIEGO , Dec. 19, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference: 42nd Annual J.P. Morgan Healthcare Co
Illumina Gives Up Fight With Regulators, Will Divest GRAIL
01:05pm, Monday, 18'th Dec 2023
The saga over DNA sequencing firm Illumina Inc.'s (ILMN) controversial purchase of cancer diagnostic test maker GRAIL appears to be over.
Illumina Stock Rises After Sale of Grail
11:04am, Monday, 18'th Dec 2023
After over two years of antitrust battles, Illumina Inc (NASDAQ:ILMN) will sell its cancer diagnostic test maker Grail through a third-party sale of capital markets transaction by the second quarter n
3 Charts For Investors to Watch Monday: Illumina, Roku, Bitcoin
09:40am, Monday, 18'th Dec 2023
Here's our daily look at three charts connected to recent news-driven price moves, with key technical levels to monitor.
Illumina shares rally as it puts Grail up for sale
09:18am, Monday, 18'th Dec 2023
Illumina Inc (NASDAQ:ILMN) stock traded on the front foot, up 5.6% to $134.25, after the company told investors it will seek a sale of its gene sequencing business Grail. It comes after European antit
Illumina to Sell Grail. It's Giving Up on its Biotech Antitrust Battle.
04:48am, Monday, 18'th Dec 2023
The decision shows the company didn't see a way to overcome regulators' objections.
Illumina to divest cancer test maker Grail
04:29pm, Sunday, 17'th Dec 2023
The divestiture will be executed through a third-party sale or capital markets transaction, San Diego-based Illumina said in a statement, adding that it would finalize the terms by second quarter of 2
Illumina To Sell Grail After U.S. Antitrust Ruling
03:52pm, Sunday, 17'th Dec 2023
Illumina said Sunday it will the sell cancer detection startup after a U.S. appeals court said the $7.1 billion deal violated antitrust laws,
Court Sides With FTC Finding Illumina-Grail Deal Anticompetitive
02:32pm, Saturday, 16'th Dec 2023
Judges also fault agency for not properly considering Illumina's plan to fix drawbacks.
Illumina: Grail's Divestment Could Unlock Significant Shareholder Value
02:16pm, Tuesday, 12'th Dec 2023
Illumina's market cap has fallen 80% from its all-time highs in 2021, but the divestment of Grail could bring it back on track. Illumina's competitive advantage lies in its scalable DNA sequencing pla
Illumina's fight with EU regulators over $7.1B Grail acquisition rages on
11:26am, Tuesday, 12'th Dec 2023
Illumina Inc (NASDAQ:ILMN), a genetic testing company, accused European Union antitrust1B regulators of overreach in their decision to stop its $7.1 billion acquisition of cancer detection test comp
Illumina files registration statement for potential Grail divestiture
01:40pm, Monday, 11'th Dec 2023
Illumina said on Monday it had filed a registration statement with the U.S. securities regulator related to a potential divestiture of Grail , even as it challenges a European Union order to divest th
Illumina (ILMN) Expands Globally Despite Macroeconomic Woes
10:32am, Monday, 11'th Dec 2023
The NovaSeq X launch strengthens Illumina's (ILMN) competitive position in high-throughput sequencing.
